Cargando…

Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH

Cancer-specific mutations can lead to peptides of unique sequence presented on MHC class I to CD8 T cells. These neoantigens can be potent tumour-rejection antigens, appear to be the driving force behind responsiveness to anti-CTLA-4 and anti-PD1/L1-based therapies and have been used to develop pers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crowley, Stephanie J., Bruck, Patrick T., Bhuiyan, Md Aladdin, Mitchell-Gears, Amelia, Walsh, Michael J., Zhangxu, Kevin, Ali, Lestat R., Jeong, Hee-Jin, Ingram, Jessica R., Knipe, David M., Ploegh, Hidde L., Dougan, Michael, Dougan, Stephanie K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058936/ https://www.ncbi.nlm.nih.gov/pubmed/32019478 http://dx.doi.org/10.1098/rsob.190235

Ejemplares similares

Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity
por: Fang, Tao, et al.
Publicado: (2017)

Anti–CTLA-4 therapy requires an Fc domain for efficacy
por: Ingram, Jessica R., et al.
Publicado: (2018)

IFNγ is a central node of cancer immune equilibrium
por: Walsh, Michael J., et al.
Publicado: (2023)

Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression
por: Walsh, Michael J, et al.
Publicado: (2023)

Inhibition of non-homologous end joining increases the efficiency of CRISPR/Cas9-mediated precise [TM: inserted] genome editing
por: Maruyama, Takeshi, et al.
Publicado: (2015)

A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
por: Quijano-Rubio, Alfredo, et al.
Publicado: (2022)

Stochastic Cytokine Expression Induces Mixed T Helper Cell States
por: Fang, Miaoqing, et al.
Publicado: (2013)

The activity of myeloid cell-specific VHH immunotoxins is target-, epitope-, subset- and organ dependent
por: Bachran, Christopher, et al.
Publicado: (2017)

Disruption of Sphingolipid Biosynthesis Blocks Phagocytosis of Candida albicans
por: Tafesse, Fikadu G., et al.
Publicado: (2015)

XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells
por: Hu, Chih-Chi Andrew, et al.
Publicado: (2009)

PD-L1 is an activation-independent marker of brown adipocytes
por: Ingram, Jessica R., et al.
Publicado: (2017)

Intestinal Colonization by Candida albicans Alters Inflammatory Responses in Bruton's Tyrosine Kinase-Deficient Mice
por: Strijbis, Karin, et al.
Publicado: (2014)

Transnuclear CD8 T cells specific for the immunodominant epitope Gra6 lower acute‐phase Toxoplasma gondii burden
por: Sanecka, Anna, et al.
Publicado: (2016)

Early BCR Events and Antigen Capture, Processing, and Loading on MHC Class II on B Cells
por: Avalos, Ana M., et al.
Publicado: (2014)

Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer
por: Yasmin-Karim, Sayeda, et al.
Publicado: (2018)

Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes
por: Hu, Chih-Chi Andrew, et al.
Publicado: (2009)

Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease
por: Maffey, Lucía, et al.
Publicado: (2016)

Protective Effect of Different Anti-Rabies Virus VHH Constructs against Rabies Disease in Mice
por: Terryn, Sanne, et al.
Publicado: (2014)

PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
por: Ali, Lestat R., et al.
Publicado: (2023)

Correction: PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
por: Ali, Lestat R., et al.
Publicado: (2023)

Class II MHC Self-Antigen Presentation in Human B and T Lymphocytes
por: Costantino, Cristina Maria, et al.
Publicado: (2012)

Intermediates in the Assembly and Degradation of Class I Major Histocompatibility Complex (MHC) Molecules Probed with Free Heavy Chain–specific Monoclonal Antibodies
por: Machold, Robert P., et al.
Publicado: (1996)

Transnuclear mice reveal Peyer's patch iNKT cells that regulate B‐cell class switching to IgG1
por: Clancy‐Thompson, Eleanor, et al.
Publicado: (2019)

DISCOVERY OF NOVEL ANTI-SERUM ALBUMIN VHH AS A BUILDING BLOCK FOR PK PROLONGATION
por: Chen, Yunying, et al.
Publicado: (2023)

Proteolysis and antigen presentation by MHC class II molecules
por: Bryant, Paula Wolf, et al.
Publicado: (2002)

Development of an Anti-Idiotypic VHH Antibody and Toxin-Free Enzyme Immunoassay for Ochratoxin A in Cereals
por: Zhang, Caixia, et al.
Publicado: (2019)

AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model
por: Marino, Marika, et al.
Publicado: (2022)

Tissue eosinophils express the IL‐33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis
por: Uchida, Amiko M, et al.
Publicado: (2021)

Type 2 immunity is maintained during cancer-associated adipose tissue wasting
por: Lenehan, Patrick J, et al.
Publicado: (2021)

FREEZING POINTS OF ANTI-COAGULANT SALT SOLUTIONS
por: Hitchcock, David I., et al.
Publicado: (1935)

Large-Scale Production of Anti-RNase A VHH Expressed in pyrG Auxotrophic Aspergillus oryzae
por: Karaman, Elif, et al.
Publicado: (2023)

Proliferation of Highly Cytotoxic Human Natural Killer Cells by OX40L Armed NK-92 With Secretory Neoleukin-2/15 for Cancer Immunotherapy
por: Guo, Meng, et al.
Publicado: (2021)

The Pathway of Us11-Dependent Degradation of Mhc Class I Heavy Chains Involves a Ubiquitin-Conjugated Intermediate
por: Shamu, Caroline E., et al.
Publicado: (1999)

GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
por: van Schie, Loes, et al.
Publicado: (2023)

Ubiquitin-Dependent Control of Class II MHC Localization Is Dispensable for Antigen Presentation and Antibody Production
por: McGehee, Annette M., et al.
Publicado: (2011)

The Availability of a Recombinant Anti-SNAP Antibody in VHH Format Amplifies the Application Flexibility of SNAP-Tagged Proteins
por: Aliprandi, Marisa, et al.
Publicado: (2010)

Search for Resonant and Non-Resonant VHH Production
por: Kyriacou, Nicholas Graves
Publicado: (2022)

Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection
por: Terryn, Sanne, et al.
Publicado: (2016)

Bioscreening and expression of a camel anti-CTGF VHH nanobody and its renaturation by a novel dialysis–dilution method
por: Xue, Xiulei, et al.
Publicado: (2016)

Expression and In Vitro Function of Anti-Breast Cancer Llama-Based Single Domain Antibody VHH Expressed in Tobacco Plants
por: Park, Se Ra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2sug9n8sp3eafgepgjl5v5gsfs